<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04945538</url>
  </required_header>
  <id_info>
    <org_study_id>ParacelsusMU</org_study_id>
    <nct_id>NCT04945538</nct_id>
  </id_info>
  <brief_title>Scatter Radiation Exposure During Coronary Procedures - The Occupational SCAtter Radiation Registry</brief_title>
  <acronym>OSCAR</acronym>
  <official_title>Quantification and Determinants of Occupational Xray Scatter Radiation Exposure of Operators and Assistants During Coronary Procedures - The Occupational SCAtter Radiation Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Paracelsus Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Paracelsus Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      During diagnostic and interventional coronary procedures scatter radiation exposure is&#xD;
      recorded with live-dosimeters at pre-specified anatomic regions of operators and sterile&#xD;
      assistants. Scatter radiation data is correlated with detailed Xray exposure data and&#xD;
      technical details of the procedure.&#xD;
&#xD;
      The purpose of the registry is:&#xD;
&#xD;
        1. to establish scatter radiation reference values based on a large number of&#xD;
           representative cath-lab procedures&#xD;
&#xD;
        2. to identify technical and clinical factors predisposing for high scatter radiation&#xD;
           exposure,&#xD;
&#xD;
        3. to evaluate advanced radiation protection devices in clinical routine.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients scheduled for diagnostic or interventional coronary procedures provide written&#xD;
      informed consent for participating in the observational OSCAR Registry. During the&#xD;
      corresponding procedures, scatter radiation exposure of operators and sterile assistants is&#xD;
      recorded using Unfors RaySafe i3 digital live dosimeters (Unfors RaySafe AB, Billdal, Sweden)&#xD;
      at 3 locations of the operator (1-frontal head at eye level, 2-left lateral head, 3-below the&#xD;
      left shoulder) and at 2 locations of the sterile assistant (1-left neck and 2-below the left&#xD;
      shoulder).&#xD;
&#xD;
      Raw data is collected in a central database and correlated with patient properties (age, BMI)&#xD;
      and detailed Xray exposure data:&#xD;
&#xD;
        -  Total dose-area product (DAP, unit of measure: Gy*cm2)&#xD;
&#xD;
        -  Number of Xray image series&#xD;
&#xD;
        -  Number of Images&#xD;
&#xD;
        -  Radiation duration (Unit of measure: Seconds)&#xD;
&#xD;
        -  Air kinetic energy released per unit mass (Kerma) Technical details of the procedure&#xD;
&#xD;
        -  Access site,&#xD;
&#xD;
        -  Clinical setting: acute or elective&#xD;
&#xD;
        -  Number of catheters used during procedure&#xD;
&#xD;
        -  Number of guidewires used during procedure&#xD;
&#xD;
        -  Number of stents implanted during procedure&#xD;
&#xD;
        -  Cumulative stent length (Unit of measure: mm)&#xD;
&#xD;
        -  Use of rotational imaging&#xD;
&#xD;
        -  Use of intracoronary pressure-wire&#xD;
&#xD;
        -  Use of optical coherence tomography (OCT)&#xD;
&#xD;
        -  Presence of bypass-vessels&#xD;
&#xD;
        -  Any occurrence of complications&#xD;
&#xD;
      The purpose of the trial is to establish a large foundation of intra-procedural scatter&#xD;
      radiation data from representative coronary procedures procedures enabling our group to&#xD;
&#xD;
        1. Establish scatter radiation reference values based on a large number of representative&#xD;
           cath-lab procedures&#xD;
&#xD;
        2. Identify technical and clinical factors predisposing for high staff scatter radiation&#xD;
           exposure&#xD;
&#xD;
        3. Evaluate advanced radiation protection devices in clinical routine.&#xD;
&#xD;
      This includes:&#xD;
&#xD;
        -  Additional ceiling-suspended lead-shielding&#xD;
&#xD;
        -  Ceiling-suspended radiation protection devices like the &quot;Zero-Gravity&quot;-System (TIDI&#xD;
           Medical Products, Neenah, WI, USA)&#xD;
&#xD;
        -  Patient lead-covers.&#xD;
&#xD;
      The study was submitted to and approved by the federal Ethics Committee Salzburg (reference&#xD;
      number ECS 1069/2021).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 9, 2021</start_date>
  <completion_date type="Anticipated">June 8, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 8, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Intra-procedural Xray scatter radiation exposure (ÂµSv)</measure>
    <time_frame>Duration of procedure</time_frame>
    <description>Xray scatter radiation dose recorded by 5 personal live dosimeters (3 allocated to the operator, 2 allocated to the sterile assistant).</description>
  </primary_outcome>
  <enrollment type="Anticipated">750</enrollment>
  <condition>Coronary Artery Disease</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Scatter radiation exposure measurement</intervention_name>
    <description>Scatter radiation exposure of the operator and sterile assistant is recorded with digital live dosimeters at 3 locations of the operator (frontal head at eye level, left lateral head, below the left shoulder) and at 2 locations of the sterile assistant (left neck and below the left shoulder)</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Two study populations have to be considered separately:&#xD;
&#xD;
          1. PDL Recordings:&#xD;
&#xD;
             Study population: Interventional cardiologists regularly assigned to our Cath-labs&#xD;
             working at the cath-lab table during the majority of their assignment.&#xD;
&#xD;
          2. Coronary procedures during which data is recorded:&#xD;
&#xD;
        Study population: Patients with clinical indication for diagnostic or interventional&#xD;
        coronary procedures, representing the classic cardiologic patient population with suspected&#xD;
        or known coronary artery disease, acute coronary syndrome or heart valve dysfunction.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient scheduled for coronary angiography&#xD;
&#xD;
          -  Diagnostic procedure and PCI&#xD;
&#xD;
          -  Acute and elective procedures&#xD;
&#xD;
          -  Standard percutaneous coronary interventions (PCI) interventions&#xD;
&#xD;
          -  Chronic total occlusion (CTO) interventions&#xD;
&#xD;
          -  Set of at least 4 personal digital live dosimeters (PDL) worn by operator and sterile&#xD;
             assistant for the entire duration of the procedure&#xD;
&#xD;
          -  Staff (operators and assistants) instructed on PDL positioning prior to procedure&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Less than 4 PDL present during the procedure&#xD;
&#xD;
          -  Incomplete data recording by at least 1 PDL&#xD;
&#xD;
          -  PDL data cannot be unambiguously assigned to a specific procedure or a specific&#xD;
             anatomical recording site&#xD;
&#xD;
          -  Exchange of operator or assistant during procedure without transfer of all PDL&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mathias C. Brandt, MD</last_name>
    <phone>+43-5-7255</phone>
    <phone_ext>58871</phone_ext>
    <email>m.brandt@salk.at</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Uta C. Hoppe, Prof.MD.</last_name>
    <phone>+43-5-7255</phone>
    <phone_ext>25601</phone_ext>
    <email>u.hoppe@salk.at</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Paracelsus Medical University, Clinic II of Internal Medicine</name>
      <address>
        <city>Salzburg</city>
        <zip>5020</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathias C. Brandt, MD</last_name>
      <phone>+43-5-7255</phone>
      <phone_ext>58871</phone_ext>
      <email>m.brandt@salk.at</email>
    </contact>
    <contact_backup>
      <last_name>Uta C. Hoppe, Prof.MD</last_name>
      <phone>+43-5-7255</phone>
      <phone_ext>25601</phone_ext>
      <email>u.hoppe@salk.at</email>
    </contact_backup>
    <investigator>
      <last_name>Mathias C. Brandt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <link>
    <url>http://stage-atcardio.multimedium.at/storage/app/media/Jahrestagung/POSTER/Interventionelle%20Kardiologie/Brandt%20.pdf</url>
    <description>Austrian Society of Cardiology 2021 Poster</description>
  </link>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 21, 2021</study_first_submitted>
  <study_first_submitted_qc>June 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 30, 2021</study_first_posted>
  <last_update_submitted>June 29, 2021</last_update_submitted>
  <last_update_submitted_qc>June 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Paracelsus Medical University</investigator_affiliation>
    <investigator_full_name>Mathias Brandt</investigator_full_name>
    <investigator_title>MD, Senior Physician, Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

